KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Accumulated Expenses (2019 - 2025)

LifeMD (LFMD) has disclosed Accumulated Expenses for 7 consecutive years, with $16.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Expenses fell 26.58% year-over-year to $16.0 million, compared with a TTM value of $16.0 million through Dec 2025, down 26.58%, and an annual FY2025 reading of $16.0 million, down 26.58% over the prior year.
  • Accumulated Expenses was $16.0 million for Q4 2025 at LifeMD, down from $22.1 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $22.1 million in Q3 2025 and bottomed at $314986.0 in Q3 2021.
  • Average Accumulated Expenses over 5 years is $7.9 million, with a median of $3.4 million recorded in 2021.
  • The sharpest move saw Accumulated Expenses soared 18949.79% in 2021, then plummeted 95.03% in 2022.
  • Year by year, Accumulated Expenses stood at $11.6 million in 2021, then tumbled by 95.03% to $576027.0 in 2022, then soared by 421.33% to $3.0 million in 2023, then surged by 624.49% to $21.8 million in 2024, then dropped by 26.58% to $16.0 million in 2025.
  • Business Quant data shows Accumulated Expenses for LFMD at $16.0 million in Q4 2025, $22.1 million in Q3 2025, and $5.5 million in Q2 2025.